Stock Taper
Latest 13F filing data - Q2 2026
| STOCK | TICKER | SHARES HELD▲ ▼ | VALUE▲ ▼ |
|---|---|---|---|
CSX Corporation | CSX | 55.95K | $2.66M |
Allogene Therapeutics, Inc. | ALLO | 54.93K | $114.26K |
Marvell Technology, Inc. | MRVL | 51.66K | $15.39M |
Amneal Pharmaceuticals, Inc. | AMRX | 50.77K | $878.88K |
Novartis AG | NVS | 49K | $7.68M |
NewAmsterdam Pharma Company N.V. | NAMS | 48.6K | $1.65M |
Vertex Pharmaceuticals Incorporated | VRTX | 48.27K | $23.97M |
PepsiCo, Inc. | PEP | 46.5K | $6.3M |
QUALCOMM Incorporated | QCOM | 45.68K | $8.44M |
Caris Life Sciences, Inc. | CAI | 44.99K | $801.7K |
Editas Medicine, Inc. | EDIT | 44.42K | $143.93K |
Sana Biotechnology, Inc. | SANA | 44.29K | $154.57K |
Unity Software Inc. | U | 43K | $1.23M |
Applied Materials, Inc. | AMAT | 41.06K | $29.69M |
| ET ESPERION THERAPEUTICS INC | ESPR | 40.97K | $129.47K |
Keurig Dr Pepper Inc. | KDP | 40.97K | $1.35M |
Palo Alto Networks, Inc. | PANW | 40.92K | $13.95M |
BioCryst Pharmaceuticals, Inc. | BCRX | 40.45K | $404.5K |
Sarepta Therapeutics, Inc. | SRPT | 40.1K | $720.63K |
Exelixis, Inc. | EXEL | 40K | $2.18M |